Lv0
0 积分 2026-06-03 加入
The future of tertiary lymphoid structures in cancer immunotherapy as biomarkers and therapeutic targets
20小时前
已完结
Preoperative CT-based topologically distinct intratumoral heterogeneity scores for predicting intratumoral tertiary lymphoid structures and outcomes in hepatocellular carcinoma: A multicenter study
20小时前
已完结
The role of ROS in tumor infiltrating immune cells and cancer immunotherapy
1个月前
已完结
Burning the candle at both ends: ROS-mediated telomere damage drives T cell dysfunction
1个月前
已完结
B cells drive CD4 T cell immunosenescence and age-associated health decline
1个月前
已完结
皖公网安备34019202002308
